In a new Publication Perspective, published in the Video Journal of Biomedicine, lead study author Vamsidhar Velcheti (New York University; NY, USA) summarizes his article, published in the journal Immunotherapy, on real-world outcomes associated with first-line pembrolizumab monotherapy for metastatic non-small-cell lung cancer with PD-L1 tumor expression ≥50%.
About the Video Journal of Biomedicine
The Video Journal of Biomedicine is a platform for authors to personally discuss their recently published paper in a short, high-quality, interview-style video. Each video allows authors to delve into their work in more detail, highlight its importance to the field and discuss its future implications. This enables viewers to gain a more comprehensive understanding of the publication.
The opinions expressed in this interview are those of the interviewee and do not necessarily reflect the views of Oncology Central or Future Science Group.